# Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses

> **NCT00777127** · PHASE4 · COMPLETED · sponsor: **MEDA Pharma GmbH & Co. KG** · enrollment: 258 (actual)

## Conditions studied

- Actinic Keratosis

## Interventions

- **DRUG:** Imiquimod
- **DRUG:** Diclofenac

## Key facts

- **NCT ID:** NCT00777127
- **Lead sponsor:** MEDA Pharma GmbH & Co. KG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 258 (ACTUAL)
- **Last updated:** 2022-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00777127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00777127, "Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT00777127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*